Close
CDMO Safety Testing 2026
Novotech

Press Releases

The world’s leading conference dedicated solely to extractables and leachables returning in a new online format

The event, renowned in the industry for providing all of the latest E&L updates, case studies and more, will take place from 1-2 December as an online event. You can expect the same unmissable content, high-calibre speakers and unique...

Novavax Announces Facility Expansion to Support Global Vaccine Development

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the expansion of its Maryland campus to accommodate the companyโ€™s rapid growth as it works to develop its candidate vaccine against COVID-19 and advance its...

AirBridgeCargo Airlines expands its partnership with Sonoco ThermoSafe to embrace new Pegasus ULD passive container

AirBridgeCargo Airlines, part of Volga-Dnepr Group, expands its Master Lease Agreement with Sonoco ThermoSafe to enable its customers worldwide to transport life-saving and healthcare products within Pegasus ULD passive container (passive container โ€“ ULD capable to maintain internal temperature...

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization,ย  announced a strategic collaboration with Synexa Life Sciences, a world-leading expert in biomarker and bioanalytical science,...

Lonza Announces Agreement to Manufacture AstraZeneca’s COVID-19 Long-Acting Antibody Combination

Lonza announced that the company has signed an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting antibodies (LAABs) for the potential prevention and treatment of COVID-19. AZD7442 is currently in Phase I clinical studies and AstraZeneca...

Kintor Pharmaceutical’s COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment

Kintor Pharmaceutical Limited is delighted to announced that the clinical trial of anti-androgen treatment Proxalutamide (GT0918) for the novel coronavirus disease (COVID-19) has reached the initial target of 381 patients enrolment on 25 October 2020. Also, it has demonstrated...

Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine

Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines. Sanofi and GSK intend to make available 200...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป